“Cancer Killers” in the March issue of Scientific American reports further on the use of synthetically produced cells to boost the immune system to destroy cancers. The treatment genetically alters a patient’s cells to make them more powerful and more efficient in their destruction of cancers like leukemia and lymphoma, and also remain on guard to resist relapse. Read more.
Advancing molecular therapies for cancer
ACGT Newsletter
Donate to ACGT
